These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

35 related articles for article (PubMed ID: 21075650)

  • 1. Safety and Efficacy of Brolucizumab in the Treatment of Diabetic Macular Edema and Diabetic Retinopathy: A Systematic Review and Meta-Analysis.
    Abu Serhan H; Taha MJJ; Abuawwad MT; Abdelaal A; Irshaidat S; Abu Serhan L; Abu Salim QF; Awamleh N; Abdelazeem B; Elnahry AG
    Semin Ophthalmol; 2024 May; 39(4):251-260. PubMed ID: 37849309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma amino acids and oxylipins as potential multi-biomarkers for predicting diabetic macular edema.
    Rhee SY; Jung ES; Suh DH; Jeong SJ; Kim K; Chon S; Yu SY; Woo JT; Lee CH
    Sci Rep; 2021 May; 11(1):9727. PubMed ID: 33958610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of metabolic parameters on clinical response to VEGF inhibitors for diabetic macular edema.
    Matsuda S; Tam T; Singh RP; Kaiser PK; Petkovsek D; Carneiro G; Zanella MT; Ehlers JP
    J Diabetes Complications; 2014; 28(2):166-70. PubMed ID: 24374138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of intravitreal bevacizumab versus intravitreal dexamethasone for diabetic macular edema: the BEVORDEX study.
    Gillies MC; Lim LL; Campain A; Quin GJ; Salem W; Li J; Goodwin S; Aroney C; McAllister IL; Fraser-Bell S
    Ophthalmology; 2014 Dec; 121(12):2473-81. PubMed ID: 25155371
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of glycemic control on visual and anatomic outcomes in response to therapy for diabetic macular edema.
    Macky TA; Mahgoub MM
    Eur J Ophthalmol; 2012 May; ():0. PubMed ID: 22653762
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of Vitreo-Macular interface abnormalities on the response to Anti-VEGF therapy for centre involving diabetic macular oedema.
    Maguire M; Laidlaw D; Davies N; Hammond C
    Graefes Arch Clin Exp Ophthalmol; 2024 May; ():. PubMed ID: 38771336
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Does HbA1c Level or Glomerular Filtration Rate Affect the Clinical Response to Endothelial Growth Factor Therapy (Ranibizumab or Aflibercept) in Diabetic Macular Edema? A Real-Life Experience.
    Debourdeau E; Medard R; Chamard C; Nguyen V; Gabrielle PH; Creuzot-Garcher C; Allieu S; Gillies MC; Barthelmes D; Daien V;
    Ophthalmol Ther; 2023 Oct; 12(5):2657-2670. PubMed ID: 37505396
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors Affecting Intensive Aflibercept Treatment Response in Diabetic Macular Edema: A Real-World Study.
    Han YE; Jo J; Kim YJ; Lee J
    J Diabetes Res; 2023; 2023():1485059. PubMed ID: 37497120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of Acquired Resistance to Anti-VEGF Therapy for Neovascular Eye Diseases.
    Sharma D; Zachary I; Jia H
    Invest Ophthalmol Vis Sci; 2023 May; 64(5):28. PubMed ID: 37252731
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preliminary Study of Different Treatment Responses between Bevacizumab, Aflibercept and Dexamethasone Implant According to Renal Function in Diabetic Macular Edema Patients.
    Moon TH; Jo GH; Seo EJ; Kim KT; Ku EJ; Kwon SK; Kim JY; Chae JB; Kim DY
    J Clin Med; 2022 Nov; 11(23):. PubMed ID: 36498627
    [TBL] [Abstract][Full Text] [Related]  

  • 11. One-year outcomes of Aflibercept for refractory diabetic macular edema in Bevacizumab nonresponders.
    Salimi A; Vila N; Modabber M; Kapusta M
    Indian J Ophthalmol; 2021 Feb; 69(2):360-367. PubMed ID: 33463593
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HbA1c as a predictor for response of bevacizumab in diabetic macular oedema.
    Sharma S; Joshi SN; Karki P
    BMJ Open Ophthalmol; 2020; 5(1):e000449. PubMed ID: 32426522
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic Factors Associated with Treatment Response in Diabetic Macular Edema.
    Wong WM; Chee C; Bhargava M; Chai C; Lin H; Zhao P; Ariadarma Mangunkusumo E; Naing T; Yuen YS; Wong TY; Su X; Lingam G
    J Ophthalmol; 2020; 2020():1875860. PubMed ID: 32280516
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intravitreal diclofenac versus intravitreal bevacizumab in persistent diabetic macular edema: Anatomical and functional outcome.
    ElBendary A; Elkannishy AH
    Saudi J Ophthalmol; 2018; 32(4):303-309. PubMed ID: 30581301
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Correlation between Changes in Biochemical Parameters and Central Macular Thickness in Patients with Non-Proliferative Diabetic Retinopathy.
    Kocak Altintas AG; Gulpamuk B; Cankurtaran V; Ilhan C; Citirik M
    Med Hypothesis Discov Innov Ophthalmol; 2018; 7(1):10-16. PubMed ID: 29644239
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficiency and safety of laser photocoagulation with or without intravitreal ranibizumab for treatment of diabetic macular edema: a systematic review and Meta-analysis.
    Qian TW; Zhao MY; Li XX; Xu X
    Int J Ophthalmol; 2017; 10(7):1134-1143. PubMed ID: 28730118
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravitreal bevacizumab injections for diabetic macular edema - predictors of response: a retrospective study.
    Joshi L; Bar A; Tomkins-Netzer O; Yaganti S; Morarji J; Vouzounis P; Seguin-Greenstein S; Taylor SR; Lightman S
    Clin Ophthalmol; 2016; 10():2093-2098. PubMed ID: 27799737
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glucose regulation influences treatment outcome in ranibizumab treatment for diabetic macular edema.
    Ozturk BT; Kerimoglu H; Adam M; Gunduz K; Okudan S
    J Diabetes Complications; 2011; 25(5):298-302. PubMed ID: 21075650
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of intravitreal bevacizumab and ranibizumab treatment for diabetic macular edema.
    Ozturk BT; Kerimoglu H; Bozkurt B; Okudan S
    J Ocul Pharmacol Ther; 2011 Aug; 27(4):373-7. PubMed ID: 21631366
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.